脑与神经疾病杂志
腦與神經疾病雜誌
뇌여신경질병잡지
JOURNAL OF BRAIN AND NERVOUS DISEASES
2014年
4期
287-291
,共5页
党哲%张国鲁%张微微%黄勇华%HUANG Yong-hua
黨哲%張國魯%張微微%黃勇華%HUANG Yong-hua
당철%장국로%장미미%황용화%HUANG Yong-hua
脑梗死%重组组织型纤溶酶原激活剂%尿激酶%静脉溶栓
腦梗死%重組組織型纖溶酶原激活劑%尿激酶%靜脈溶栓
뇌경사%중조조직형섬용매원격활제%뇨격매%정맥용전
Brain infarction%Recombinant tissue plasminogen activator%Urokinase%Thrombolysis
目的:观察重组组织型纤溶酶原激活剂联合尿激酶静脉溶栓治疗急性脑梗死的疗效与安全性。方法选择前循环急性脑梗死患者171例,联合溶栓组46例,单用rt-PA组39例,单用尿激酶组34例,对照组52例。观察治疗前及治疗后14d NIHSS评分,同时观察再梗死率、脑出血率及死亡率。结果4组治疗后14d分别和治疗前比较,差异有统计学意义( P<0.05);3个溶栓组与对照组14d有效率差异有统计学意义( P<0.05);4组再发脑梗死率、死亡率差异无统计学意义( P>0.05),联合溶栓组脑出血率与单用rt-PA组及单用尿激酶组差异均有统计学意义( P<0.05)。结论 rt-PA联合尿激酶治疗急性脑梗死是安全有效的。
目的:觀察重組組織型纖溶酶原激活劑聯閤尿激酶靜脈溶栓治療急性腦梗死的療效與安全性。方法選擇前循環急性腦梗死患者171例,聯閤溶栓組46例,單用rt-PA組39例,單用尿激酶組34例,對照組52例。觀察治療前及治療後14d NIHSS評分,同時觀察再梗死率、腦齣血率及死亡率。結果4組治療後14d分彆和治療前比較,差異有統計學意義( P<0.05);3箇溶栓組與對照組14d有效率差異有統計學意義( P<0.05);4組再髮腦梗死率、死亡率差異無統計學意義( P>0.05),聯閤溶栓組腦齣血率與單用rt-PA組及單用尿激酶組差異均有統計學意義( P<0.05)。結論 rt-PA聯閤尿激酶治療急性腦梗死是安全有效的。
목적:관찰중조조직형섬용매원격활제연합뇨격매정맥용전치료급성뇌경사적료효여안전성。방법선택전순배급성뇌경사환자171례,연합용전조46례,단용rt-PA조39례,단용뇨격매조34례,대조조52례。관찰치료전급치료후14d NIHSS평분,동시관찰재경사솔、뇌출혈솔급사망솔。결과4조치료후14d분별화치료전비교,차이유통계학의의( P<0.05);3개용전조여대조조14d유효솔차이유통계학의의( P<0.05);4조재발뇌경사솔、사망솔차이무통계학의의( P>0.05),연합용전조뇌출혈솔여단용rt-PA조급단용뇨격매조차이균유통계학의의( P<0.05)。결론 rt-PA연합뇨격매치료급성뇌경사시안전유효적。
Objective To observe the efficacy and safety of combined thrombolytic therapy with recombinant tissue plasminogen activator (rt-PA)and urokinase(UK) on patients with acute cerebral infarction.Methods 171 hospitalized patients with acute cerebral infarction were assigned into our study and randomly allocated into four groups:combined thrombolysis group ( n=46) ,rt-PA group ( n=39) ,UK group ( n=34) ,and control group ( n=52) . The outcome score were evaluated according to NIHSS before treatment and 14 days after symptom onset .The hemorrhagic transformation ,recurrent infarction and death as the safety indicators were assessed as well.Results There were significant differences in each group before and after 14 days treatment (P<0.05).There were significant differences between 3 thrombolysis groups and control group at 14 days about an efficient and satisfactory outcome rate ( P<0.05) .There were no significant differences in stroke recurrence rate , mortality, symptomatic intracerebral hemorrhage rate and non-symptomatic intracerebral hemorrhage rate ( P>0.05) .There were significant differences between combined thrombolysis group and rt-PA group (P<0.05) and between combined thrombolysis group and UK group ( P<0.05) .Conclusion The combined thrombolytic therapy with rt-PA and UK for the treatment of acute cerebral infarction is safe and effective .